Immunotherapy for Nonmelanoma Skin Cancer: Facts and Hopes

2022
CSCC
BCC
Merkel Cell Carcinoma
Authors

Sophia Z. Shalhout

Howard L. Kaufman

Kevin S. Emerick

David M. Miller

Published

May 31, 2022

Doi

https://doi.org/10.1007/s11912-021-01120-z

Abstract
We review the latest trends in cancer care for Nonmelanoma skin cancer. Published in Clinical Cancer Research, June 2022.

Journal: Clinical Cancer Research.

Authors: Sophia Z. Shalhout, PhD1,2, Howard L. Kaufman, MD, PhD,3, Kevin S. Emerick,4, MD,and David Michael Miller, MD, PhD1,2

Affiliations:
1 Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Bartlett Hall, Room 132, 15 Parkman St, Boston, MA 02114, USA
2 Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Bartlett Hall, Room 132, 15 Parkman St, Boston, MA 02114, USA
3 Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
4 Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA

Reference:

Shalhout, Sophia Z., Howard L. Kaufman, Kevin S. Emerick, and David M. Miller. 2022. “Immunotherapy for Nonmelanoma Skin Cancer: Facts and Hopes.” Clinical Cancer Research 28 (11): 2211–20. https://doi.org/10.1158/1078-0432.ccr-21-2971.